Pulmonx
Alex Yang has extensive experience in research and development within the medical technology sector, currently serving as a Senior Program Manager at Pulmonx Corporation since January 2009, where previous roles included R&D Manager, R&D Project Manager, and Senior R&D Engineer. Prior to this, Alex held the position of Senior R&D Engineer at Foxhollow Technologies (ev3) from August 2005 to November 2008 and worked as an R&D Engineer at Bacchus Vascular from August 2003 to August 2005. Alex earned a Bachelor of Science degree in Bioengineering and Biomedical Engineering from the University of California, Berkeley, between 1999 and 2003.
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1